Improvement of the psycho-emotional state and cytokine profile of patients with rheumatoid ­arthritis and hepatic steatosis after therapy with thioctic (lipoic) acid and methotrexate

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The social significance of such inflammatory diseases as rheumatoid arthritis is growing all over the world, which determines the need to find new ways to optimize the ongoing standard therapy.

Aim. Evaluation of the effect of combined use of thioctic (lipoic) acid with methotrexate in comparison with methotrexate and meloxicam therapy on the psycho-emotional state of patients with rheumatoid arthritis and hepatic steatosis.

Material and methods. The study included 60 women diagnosed with rheumatoid arthritis and hepatic steatosis. By the beginning of the observation, patients divided into two groups were comparable according to all criteria for inclusion in the study. The first group took methotrexate and thioctic (lipoic) acid, the second group — methotrexate and meloxicam daily for a month. The psycho-emotional state of the patients according to the Spielberger tests modified by Yu.L. Khanin and depression according to Beck were assessed. Determination of pro-inflammatory cytokines was carried out by enzyme immunoassay. The research results were subjected to statistical processing.

Results. An intergroup analysis showed that the use of thioctic acid and methotrexate led to a significant decrease in the level of anxiety in patients, in contrast to women taking methotrexate and meloxicam (the level of reactive anxiety decreased by 2.7 times compared with baseline data; p=0.03). It is also important to note the revealed correlation between the degree of decrease in the level of tumor necrosis factor α and the severity of anxiety 1 month after taking the cytostatic and the hepatoprotector (Kendal's Tay-b correlation coefficient, r=0.732, p=0.046).

Conclusion. The inclusion of thioctic (lipoic) acid in the basic therapy with methotrexate in patients with rheumatoid arthritis and hepatic steatosis improves their psycho-emotional state in the form of a decrease in anxiety-depressive spectrum disorders, practically normalizing the level of pro-inflammatory tumor necrosis factor α, the degree of reduction of which correlates with the degree of reduction in the level of anxiety.

Full Text

Restricted Access

About the authors

Alsu N. Gainetdinova

Kazan State Medical University

Author for correspondence.
Email: alsu.doc@mail.ru
ORCID iD: 0000-0002-7783-6426

M.D., Cand. Sci. (Med.), Assistant, Depart. of Hospital Therapy

Russian Federation, Kazan, Russia

Luisa N. Zalyalyutdinova

Kazan State Medical University

Email: zalyalyu@gmail.com
ORCID iD: 0000-0001-9605-0720

M.D., D. Sci. (Med.), Prof., Depart. of Pharmacology

Russian Federation, Kazan, Russia

Диана Ильдаровна Абдулганиева

Kazan State Medical University

Email: diana_s@mail.ru
ORCID iD: 0000-0001-7069-2725

M.D., D. Sci. (Med.), Prof., Head of Depart., Depart. of Hospital Therapy

Russian Federation, Kazan, Russia

References

  1. Nasonov EL. Progress in rheumatology in the early 21st century. Modern Rheumatology Journal. 2014;(3):4–8. doi: 10.14412/1996-7012-2014-3-4-8.
  2. Rossiyskie klinicheskie rekomendatsii. Revmatologiya. (Russian clinical guidelines. Rheumatology.) Nasonov EL, editor. Moscow: GEOTAR-Media; 2017. 464 р. (In Russ.)
  3. Gaynetdinova AN, Zalyalyutdinova LN, Abdulganieva DI, Imanaeva AYa, Gayfullin AN. Experimental basis of thioctic acid addicton to methotrexate in combined therapy of rheumatoid arthritis by adjuvant arthritis model. Prakticheskaya meditsina. 2015;(4-2):19–23. (In Russ.)
  4. Zeltyn’ AE, Vel’tischev DYu, Fofanova YuS, Lisitsyna TA, Drozhzhina EN, Kovalevskaya OB, Seravina OF, Nasonov EL. Rheumatoid arthritis and depression: the pathogenetic role of stress factors (literature review). Psikhicheskie rasstroystva v obshchey meditsine. 2010;(1):48–51. (In Russ.)
  5. Smolen JS, Landewe R, Breedveld FC, Buch М, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma WJ, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes MWJ, Kouloumas M, Kvien KT, Mariett X, Pavelka K, van Riel LCMP, Rubbert-Roth A, Scholte-Voshaar M, Scott LD, Sokka-Isler T, Wong BJ, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509. doi: 10.1136/annrheumdis-2013-204573.
  6. Diagnostika i lechenie nealkogol’noy zhirovoy bolezni pecheni. Metod. rekomendatsii dlya vrachey. (Diagnosis and treatment of non-alcoholic fatty liver disease. Method. recommendations for doctors.) Ivashkin VT, editor. Moscow: MEDpress-inform; 2012. 32 р. (In Russ.)
  7. Rosenberger WF, Lachin JM. Randomization in clinical trial: Theory and practice. WILEY-Interscience; 2005. 278 р.
  8. Spielberger CD. The State-trait Anxiety Inventory (STAI): Test Manual for Form X. Palo Alto: Consulting Psychologists Press; 1968. 365 р.
  9. Kratkoe rukovodstvo k primeneniyu shkaly reaktivnoy i lichnostnoy trevozhnosti ChD Spilbergera. (A brief guide to the use of the CD Spielberger scale of reactive and personal anxiety.) YuL Khanin ed. Leningrad: LNIIFK; 1976. 18 р. (In Russ.)
  10. Beck AT, Ward CM, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004.
  11. Novikov AA, Alexandrova EN, Diatroptova MA, Nasonov EL. Role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology science and practice. 2010;(2):71–82. (In Russ.)
  12. Kovalenko VN. Rheumatic diseases: the current trends of pharmacotherapy. Ukrainskyj revmatologichnyj zhurnal. 2009;(3):5–11. (In Ukr.)
  13. Lysenko GI, Tkachenko VI. Psychoemotional aspects of chronic pain in patients with rheumatoid arthritis. Zdorov’e Ukrainy. 2008;(10):66–67. (In Russ.)
  14. Abramkin AA, Lisitsyna TA, Veltishchev DYu, Seravina OF, Kovalevskaya OB, Glukhova SI, Nasonov EL. Depression and severity of articular destruction in patients with rheumatoid arthritis. Terapevticheskiy arkhiv. 2020;(5):22–32. (In Russ.) doi: 10.26442/00403660.2020.05.000624.
  15. Zalyalyutdinova LN, Fardieva RM, Gaynetdinova AN. Study of neurotropic properties of lipoic acid in the experiment. Modern problems of science and education. 2014;(6):1196. (In Russ.) doi: 10.17513/spno.16847.
  16. Zalyalyutdinova LN, Gainetdinova AN, Abdulganieva DI, Ulyanina LR. Results of long-term combined administration of thioctic acid and methotrexate in animals with adjuvant arthritis model. Eksperimentalnaya i klinicheskaya farmakologiya. 2016;79(8):23–28. (In Russ.) doi: 10.30906/0869-2092-2016-79-8-23-28.
  17. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med. 2000;160:2101–2107. doi: 10.1001/archinte.160.14.2101.
  18. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32:1013–1019. PMID: 15940760.
  19. Shulpekova YuO, Ivashkin VT. Application of thioctic acid in gastroenterology. Russkiy meditsinskiy zhurnal. 2000;(15):630. (In Russ.)
  20. Molchanova OV, Kochkarov VI, Pokrovskiy MV, Korokin MV, Gudyrev OS. Alpha-lipoic (thioctic) acid pharmacological effects. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Meditsina. Farmatsiya. 2012;(22-3):24–29. (In Russ.)
  21. Halimov YuSh, Salukhov VV. Thioctic acid: from cellular mechanisms of regulation to clinical practice. Effektivnaya farmakoterapiya. 2012;(46):22–29. (In Russ.)
  22. Korshunov NI, Yal’tseva NV, Grigor’eva EA, Rechkina EV. Use of antidepressants in patients with inflammatory (rheumatoid arthritis) and non-inflammatory (lower back pain syndrome) diseases of the musculoskeletal system. Russkiy meditsinskiy zhurnal. 2010;(11);752–755. (In Russ.)

Supplementary files

There are no supplementary files to display.


© 2023 Eco-Vector




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies